Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy

International Journal of Radiation Oncology Biology Physics

Volumn 54, Issue 2, 2002, Pages 329-339

  Yorke, Ellen D ^a   Jackson, Andrew ^a   Rosenzweig, Kenneth E ^a   Merrick, Scott A ^a   Gabrys, Dorota ^b   Venkatraman, Ennapadam S ^a   Burman, Chandra M ^a   Leibel, Steven A ^a   Ling, C Clifton ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Dose volume histograms; Lung cancer; Normal tissue complications; Three dimensional treatment planning

Indexed keywords

DOSIMETRY; PATIENT TREATMENT; PULMONARY DISEASES; TOXICITY; TUMORS;

CONFORMAL RADIATION;

RADIATION;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSIMETRY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; LUNG STRUCTURE; LUNG TOXICITY; MALE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION PNEUMONIA; RISK ASSESSMENT;

EID: 0036803125     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02929-2     Document Type: Article

References (26)

1. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 21:1991;109-122.
2. Robertson J.M., Ten Haken R.K., Hazuka M.B., et al. Dose escalation for non-small-cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys. 37:1997;1079-1085.
3. Emami B. Three-dimensional conformal radiation therapy in bronchogenic carcinoma. Semin Radiat Oncol. 6:1996;92-97.
4. Armstrong J., Raben A., Zelefsky M., et al. Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer. Radiother Oncol. 44:1997;17-22.
5. Oetzel D., Schraube P., Hensley F., et al. Int J Radiat Oncol Biol Phys. 33:1995;455-460.
6. Kwa S.L.S., Lebesque J.V., Theuws J.C.M., et al. Radiation pneumonitis as a function of mean lung dose An analysis of pooled data of 540 patients . Int J Radiat Oncol Biol Phys. 42:1998;1-9.
7. Kwa S.L.S., Theuws J.C.M., Wagenaar A., et al. Evaluation of two dose-volume histogram reduction models for the prediction of radiation pneumonitis. Radiother Oncol. 48:1998;61-69.
8. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity A dose-volume histogram analysis in 201 patients with lung cancer . Int J Radiat Oncol Biol Phys. 51:2001;650-659.
9. Martel M.K., Ten Haken R.K., Hazuka M.B., et al. Dose volume histogram and 3-D treatment planning evaluation of patients with pneumonitis. Int J Radiat Oncol Biol Phys. 28:1994;578-581.
10. Rosenzweig K.E., Mylchalczak B., Fuks Z., et al. Final report of the 70.2 Gy and 75.6 Gy dose levels of a phase 1 dose escalation study using three dimensional conformal radiotherapy in the treatment of inoperable lung cancer. Cancer J Sci Am. 6:2000;82-87.
11. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 45:1999;323-329.
12. Withers H.R., Taylor J.M.G., Maciejewski B. Treatment volume and tissue tolerance. Int J Radiat Oncol Biol Phys. 15:1988;751-759.
13. Yorke E.D., Kutcher G.J., Jackson A., et al. Probability of radiation-induced complications in normal tissues with parallel architecture under conditions of uniform whole or partial organ irradiation. Radiother Oncol. 26:1993;226-237.
14. Jackson A., Kutcher G.J., Yorke E.D. Probability of radiation-induced complications for normal tissues with parallel architecture subject to non-uniform irradiation. Med Phys. 20:1993;613-625.
15. Travis E.L., Liao Z.X., Tucker S.L. Spatial heterogeneity of the volume effect for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys. 38:1997;1045-1054.
16. Tucker S.L., Liao Z.X., Travis E.L. Estimation of the spatial distribution of target cells for radiation pneumonitis in mouse lung. Int J Radiat Oncol Biol Phys. 38:1997;1045-1054.
17. Moiseenko V.V., Battista J.J., Hill R.P., et al. In-field and out-of-field effects in partial volume lung irradiation in rodents Possible correlation between early DNA damage and functional endpoints . Int J Radiat Oncol Biol Phys. 48:2000;1539-1548.
18. European Organization for Research and Treatment of Cancer (EORTC), Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG). Int J Radiat Oncol Biol Phys. 31:1995;1341-1346.
19. Mohan R., Barest G., Brewster L.I., et al. A comprehensive three-dimensional radiation treatment planning system. Int J Radiat Oncol Biol Phys. 15:1988;481-495.
20. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res. 104:1985;S13-S19.
21. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 21:1991;123-135.
22. Kutcher G.J., Burman C. Calculation of complication probability factors for nonuniform normal tissue irradiation The effective volume method . Int J Radiat Oncol Biol Phys. 21:1991;137-146.
23. Jackson A., Ling C.C., Burman C.M., et al. A conformal dose escalation protocol for the treatment of tumors in the lung or other normal tissues with parallel architecture. (Abstr) Med Phys. 23:1996;1495.
24. Yorke E., Jackson A., Rosenzweig K., et al. The Lyman model and a current parallel model Are they equivalent in predicting radiation induced lung toxicity . CD-ROM Proceedings of the World Congress on Medical Physics and Biomedical Engineering, July 23-28. 2000.
25. West J.B. Respiratory physiology, the essentials. 4th edition: 1990;61-64 Williams and Wilkins, Baltimore, MD.
26. Jackson A., Ten Haken R.K., Robertson J.M., et al. Analysis of clinical complication data for radiation hepatitis using a parallel architecture model. Int J Radiat Oncol Biol Phys. 31:1995;883-891.